| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f84c72548314e7fcde45c45c79710a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate |
1994-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf36b273e38a1497a1e326134bf3f25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02fc16dd6edfe72020f37af1752e2767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92b1e1523dc6715293d518133664e89 |
| publicationDate |
1995-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0688223-A1 |
| titleOfInvention |
$i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS |
| abstract |
This invention is directed to a method for assaying the degree of activation of immune cells by stimulating non-resting immune cells to activity with a stimulant and then measuring the activity of the stimulated immune cells. The stimulant that can be used in this invention will effectively stimulate non-resting immune cells to activity but, will not effectively stimulate resting immune cells to activity. The stimulants that can be used in the invention of this assay act directly as activation probes. These stimulants can discern evidence of previous immune cell activation and will therefore effectively stimulate to activity primed immune cells. Since the stimulant discerns previous immune cell activation, the stimulants of this invention will not effectively stimulate to activity resting immune cells. The assay measurements can be used for the variety of evaluations, including correlating in vitro activity with clinical outcome of the therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4929272-A |
| priorityDate |
1993-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |